Minimum 6-year outcomes for interstitial cystitis treated with sacral neuromodulation

Introduction and hypothesis Interstitial cystitis is a multifaceted medical condition consisting of pelvic pain, urgency, and frequency. Can sacral neuromodulation be successfully utilized for the medium term of ≥6 years in interstitial cystitis patients for whom standard drug therapies have failed? Methods In our observational, retrospective, case-controlled review (January 2002–March 2004), we sought to discern whether neuromodulation could be successfully implemented with acceptable morbidity rates in interstitial cystitis patients. Thirty-four female patients underwent stage 1 and 2 InterStim placements under a general anesthetic. Simple means and medians were analyzed. Results Mean pre-op/post-op pelvic pain and urgency/frequency scores were 21.61 ± 8.6/9.22 ± 6.6 ( p